3D-Printing with precise layer-wise dose adjustments for paediatric use via pressure-assisted microsyringe printing.


Journal

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 26 05 2020
revised: 17 08 2020
accepted: 21 09 2020
pubmed: 7 10 2020
medline: 3 8 2021
entrez: 6 10 2020
Statut: ppublish

Résumé

The establishment of 3D-printing as manufacturing process for oral solid dosage forms enables new options for the individualized medicine. The aim of this work was to develop a novel drug-printing model using pressure-assisted microsyringe (PAM) technology, which allows the precise dispensing of drug substances. Printed tablets with different numbers of layers, mimicking different doses for pediatric subgroups, were analyzed regarding mass variation, friability, thickness and disintegration time. Furthermore, the uniformity of dosage units and the dissolution behavior were investigated. Friability was <0.3% in all cases, which demonstrates the ability of PAM printing to manufacture robust solid dosage. Disintegration results showed the dependency of the disintegration on the number of layers and therefore on the compact mass of polymer. However, all tablets disintegrated within 3 min and fulfilled the requirements of immediate release tablets of the USP and orodispersible tablets according to the Ph. Eur. Results of uniformity dosage units confirmed the successful manufacturing of the intended individualized doses. Drug dissolution appeared to be dependent on the number of layers. An increase of layers resulted in a decrease of the drug release rate. Further, the drug release could be correlated to the surface area/volume (SA/V) ratio.

Identifiants

pubmed: 33022389
pii: S0939-6411(20)30289-7
doi: 10.1016/j.ejpb.2020.09.012
pii:
doi:

Substances chimiques

Anticonvulsants 0
Tablets 0
Levetiracetam 44YRR34555

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-65

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Ilias El Aita (I)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University Duesseldorf, Universitaetsstr. 1, 40225 Duesseldorf, Germany.

Jhinuk Rahman (J)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University Duesseldorf, Universitaetsstr. 1, 40225 Duesseldorf, Germany; INVITE GmbH, Otto-Bayer-Str. 32, 51061 Koeln, Germany.

Jörg Breitkreutz (J)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University Duesseldorf, Universitaetsstr. 1, 40225 Duesseldorf, Germany.

Julian Quodbach (J)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University Duesseldorf, Universitaetsstr. 1, 40225 Duesseldorf, Germany. Electronic address: julian.quodbach@uni-duesseldorf.de.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans Surgical Staplers Surgical Stapling Postoperative Complications Treatment Outcome
Tissue Plasminogen Activator Retina Air Pressure Humans

Characterization of 3D printed composite for final dental restorations.

Lucas Eigi Borges Tanaka, Camila da Silva Rodrigues, Manassés Tércio Vieira Grangeiro et al.
1.00
Composite Resins Materials Testing Printing, Three-Dimensional Surface Properties Flexural Strength

Classifications MeSH